论文部分内容阅读
<正> OBJECTIVE To evaluate the clinical effectivity and toxicity ofthe regimen FMD (fludarabine,mitoxantrone,dexamethasone) inpatients with non-Hodgkin's lymphoma.METHODS Thirty-two patients,twenty-four of whom hadindolent B-cell lymphoma,6 perip